Mainz, Germany — BioNTech SE, the German biotechnology firm that achieved global recognition for its pivotal role in developing the…
Read More
BioNTech’s Post-Pandemic Pivot: From €19 Billion Vaccine Bonanza to Oncology’s €16.8 Billion Bet Amidst Job Cuts and Shifting mRNA Landscape
The German biotechnology firm BioNTech, a name synonymous with the rapid development of the world’s first widely authorized mRNA COVID-19…
Read More
BioNTech’s Dramatic Pivot: From €19B COVID Vaccine Fortunes to 1,860 Job Cuts and a €16.8B Oncology Bet
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine Comirnaty, is undergoing a profound strategic transformation, shedding…
Read More
BioNTech’s Dramatic Pivot: From Pandemic Powerhouse to Oncology Challenger Amidst Job Cuts and Shifting Fortunes
The German biotechnology firm BioNTech, once a beacon of innovation and a financial titan thanks to its pioneering mRNA COVID-19…
Read More
Amazon Bio Discovery Cuts MSK Antibody Design from a Year to Weeks, AWS Says
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a sophisticated application designed to significantly accelerate the…
Read More
Amazon Bio Discovery Accelerates Drug Development, Cuts MSK Antibody Design from a Year to Weeks
Amazon Web Services (AWS) has unveiled Amazon Bio Discovery, a groundbreaking application designed to dramatically accelerate the drug discovery process,…
Read More
Regeneron cuts White House pricing deal, offers new gene therapy for free – Pharmaceutical Technology
Regeneron Pharmaceuticals has entered into a significant drug pricing agreement with the White House, marking a pivotal moment in the…
Read More
New drug cuts seizures by up to 91% in children with rare epilepsy
In a landmark development for pediatric neurology, an international clinical trial has demonstrated that an experimental genetic therapy, zorevunersen, can…
Read More
